Dan Veru

Dan Veru

Presidente presso
Palisade Capital Management LP
64 anni
Finance
Health Technology
Commercial Services

Profilo

Mr. Dennison T.
Veru is a Senior Partner & Chief Investment Officer at Palisade Capital Management LP, a Senior Partner and Chief Investment Officer at Palisade Capital Management (Private Equity) and a Member at Dwight-Englewood School, Inc. He is on the Board of Directors at Palisade Capital Management LP and The Mccarton School.
Mr. Veru was previously employed as a Chairman by Anchiano Therapeutics Ltd., an Independent Director by Brickell Biotech, Inc., a President by Awad Asset Management, Inc., a Principal by Drexel Burnham Lambert, Inc., a Principal by Smith Barney Harris Upham & Co., Inc., and a Non-Executive Director by Stockcube Ltd. He also served on the board at Vical, Inc., OptiCare Health Systems, Inc., REFAC Optical Group, Inc., Lois/USA, Inc. and Brickell Subsidiary, Inc. He received his undergraduate degree from Franklin & Marshall College.

Posizioni attive di Dan Veru

SocietàPosizioneInizio
Presidente 01/02/2000
Direttore degli Investimenti 29/03/2010
Corporate Officer/Principal -
Direttore/Membro del Consiglio -

Precedenti posizioni note di Dan Veru

SocietàPosizioneFine
FRESH TRACKS THERAPEUTICS, INC. Direttore/Membro del Consiglio 28/07/2022
ANCHIANO THERAPEUTICS LTD Presidente 17/05/2020
Direttore/Membro del Consiglio 04/03/2014
Direttore/Membro del Consiglio 07/05/2007
Direttore della Ricerca - Azioni 01/01/2000
Vedi nel dettaglio l'esperienza di Dan Veru

Formazione di Dan Veru

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

56

Relazioni di 1° grado

16

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private16

Finance

Retail Trade

Health Technology

Commercial Services

Finance

Health Services

Health Technology

Health Technology

Process Industries

Finance

Consumer Services

Finance

Consumer Services

Finance

Commercial Services

Health Technology

-40% : Prolongation exceptionnelle ➤➤➤➤
g
:
:
ENTRA ORA